These tumors often exhibit elevated expression of lipid-related enzymes (e.g., FASN, ACC), transporters (CD36), and regulators (SREBP1), all of which support tumor growth, metastasis, and immune evasion. This evidence concerns the gene SREBF1 and neoplasm.